Ignite Creation Date:
2025-12-24 @ 6:30 PM
Ignite Modification Date:
2025-12-24 @ 6:30 PM
Study NCT ID:
NCT04396457
Status:
UNKNOWN
Last Update Posted:
2023-03-23
First Post:
2020-01-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
Sponsor:
National Hospital Organization Nagoya Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-14
First Submit QC Date:
None
Study First Post Date:
2020-05-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-21
Last Update Post Date:
2023-03-23
Last Update Post Date Type:
ACTUAL